SFA
LGND icon

Sequoia Financial Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Sequoia Financial Advisors’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$370K Sell
1,169
-35
-3% -$8.25K ﹤0.01% 1530
2026
Q1 		$240K Buy
+1,204
New +$238K ﹤0.01% 1689
2024
Q3 		– Sell
-4,029
Closed -$339K – 1333
2024
Q2 		$339K Buy
+4,029
New +$321K ﹤0.01% 837

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sequoia Financial Advisors's LGND Position: Q2 2026 in Review

Sequoia Financial Advisors reduced its Ligand Pharmaceuticals (LGND) stake by 2.9% in Q2 2026, selling an estimated $8.25K and leaving 1,169 shares worth $370K. The position accounts for ﹤0.01% of the portfolio, ranked #1530.

Sequoia Financial Advisors first reported a position in LGND in Q2 2024 and has held it in 3 quarters since. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Sequoia Financial Advisors held 1,169 shares of Ligand Pharmaceuticals worth $370K as of Q2 2026.
  • Sequoia Financial Advisors sold 35 Ligand Pharmaceuticals shares in Q2 2026, an estimated $8.25K.
  • Ligand Pharmaceuticals made up ﹤0.01% of Sequoia Financial Advisors's portfolio in Q2 2026, its #1530 holding.
  • Sequoia Financial Advisors first reported a position in Ligand Pharmaceuticals in Q2 2024 and has held it in 3 quarters since.
  • 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.